Prenetics, a Covid-19 Testing Startup, to Go Public in SPAC Merger

  • 📰 WSJ
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

United States News News

United States United States Latest News,United States United States Headlines

Covid-19 testing startup Prenetics Group is going public in a deal valuing it at $1.25 billion—the latest in a string of medical diagnostic companies to go public via a SPAC

Hong Kong-based Prenetics Group Ltd. is going public on the Nasdaq Stock Market via a special-purpose acquisition company, in a deal that values the medical diagnostic startup at $1.25 billion.

Prenetics, whose revenue has surged during the coronavirus pandemic, will merge with Artisan Acquisition Corp. , a blank-check company founded by Adrian Cheng,

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines